January 4th, 2017
A BEAM research team will be awarded a new R01 grant from the National Institutes for Health. This $1.8 million, 5-year award from the NCI supports a research project led by BEAM faculty Rafael Davalos and Scott Verbridge titled “High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment”. The work, in collaboration with John Robertson in BEAM, John Rossmeisl in the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski and Glenn Lesser of the Wake Forest Brain Tumor Center of Excellence, will support the team in advancing a new paradigm of brain cancer therapy that ultimately seeks to improve clinical outcomes by combining a novel electric field-based tumor ablation method invented at Virginia Tech with more traditional drug-based treatments. This award is a result of the ongoing and uniquely collaborative cancer research within BEAM and the Virginia Tech - Wake Forest School of Biomedical Engineering and Mechanics that leverages the engineering and veterinary oncology expertise at Virginia Tech, and the clinical expertise at the Wake Forest Medical School.